Suchergebnisse - "Grant, Robert C"

PubPharm (72)

11

Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature

enthalten in: Journal of clinical pathology | 2023

von Allen, M. | Zhang, A. | Bavi, P. | +15

12

Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis

enthalten in: Journal of gastrointestinal oncology | 2023

von Holzapfel, N. | Zhang, A. | Choi, W. | +11

13

Demographics, pattern of practice and clinical outcomes in rectal squamous cell carcinoma

enthalten in: Colorectal Disease | 2023

von Id Said, B. | Buchan, D. | Liu, Z. | +8

14

Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival

enthalten in: Gastroenterology | 2022

von Pai, R. | Banerjee, I. | Shivji, S. | +22

15

hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Perera, S. | Jang, G. | Wang, Y. | +19

16

Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2022

von Wang, Y. | Cuggia, A. | Chen, Y. | +20

17

Correction : GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von O'Kane, G. | Grünwald, B. | Jang, G. | +25

ErratumFor: Clin Cancer Res. 2020 Sep 15;26(18):4901-4910. - PMID 32156747

18

Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation

enthalten in: Future oncology (London, England) | 2022

von Azhie, A. | Grant, R. | Herman, M. | +3

19

Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation

enthalten in: European radiology | 2022

von Healy, G. | Salinas-Miranda, E. | Jain, R. | +13

20

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma

enthalten in: Frontiers in oncology | 2022

von Golesworthy, B. | Wang, Y. | Tanti, A. | +23